Company

Phi Pharma SA is a private Switzerland-based biopharmaceutical company. It specializes in the discovery and early clinical development of peptide drug conjugates …

see More

Technology 

Phi Pharma technology differentiation resides in providing a peptide alternative to Antibody-Drug-Conjugates (ADC) with a new paradigm...

See More

Programs

Phi Pharma develops innovative peptide drug conjugates against multiple myeloma, acute myeloid leukaemia and other B-Cell derived malignancies. In parallel...

see more